Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Miami | 388 Studies

Clinical Trials Breast CancerMiami

Breast Cancer Clinical Trials in Miami

Find 388 clinical trials for breast cancer near Miami, Florida. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Miami

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 388 trials

CompletedSurgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast CancerRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00881361·Mobile, Alabama and 323 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedAvelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)This is a Phase 1, open-label, dose-escalation trial of avelumab \[antibody targeting programmed death ligand 1 (anti PD-L1)\] with consecutive parallel group expansion in…NCT01772004·Goodyear, Arizona and 73 others

CompletedEverolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal WomenThe purpose of this study is to examine the effect of the combination of everolimus and letrozole compared to placebo and letrozole as pre-surgical therapy in patients with newly…NCT00107016·Springdale, Arkansas and 45 others

RecruitingA Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p53 R175H mutation.NCT06778863·Scottsdale, Arizona and 20 others

CompletedGalinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced CancersTo evaluate the safety, tolerability, and anti-tumor activity of galinpepimut-S in combination with pembrolizumab in patients with selected advanced cancers.NCT03761914·Santa Rosa, California and 11 others

Active not recruitingRegional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast CancerThe purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation…NCT03488693·Fairbanks, Alaska and 484 others

RecruitingA Study of LY4257496 in Participants With Cancer (OMNIRAY)The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relevant standard of care (SOC) combination therapy in…NCT07114601·Duarte, California and 32 others

CompletedWhole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast CancerRSR13 (efaproxiral) is a radiation sensitizer that has shown positive results in a Phase 3, randomized clinical trial of patients with brain metastases.NCT00083304·Phoenix, Arizona and 93 others

TerminatedRandomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerThe purpose of this study is to assess the effect of ixabepilone plus capecitabine or docetaxel plus capecitabine on shrinking or slowing the growth of metastatic breast cancer in…NCT00546364·Tuscaloosa, Alabama and 59 others

CompletedS1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast CancerRATIONALE: Measuring how text-message affects treatment compliance in women with breast cancer may help doctors plan the best treatment.NCT01515800·Anchorage, Alaska and 203 others

CompletedA Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerThe goal of this study was to determine the effect on overall survival and progression free survival by adding iniparib (BSI-201/SAR240550) to the combination of…NCT00938652·Birmingham, Alabama and 101 others

CompletedProspective Evaluation of Targeted Axillary Dissection (TAD)The purpose of this research is to evaluate how to manage the axillary lymph nodes in patients with breast cancer.NCT04998682·Miami, Florida

CompletedPhase 2 Study of Imprime PGG and Pembrolizumab in Patients With HR+/HER2- Metastatic Breast Cancer (mBCA)The primary objective of this Phase 2 Simon 2-Stage study is to determinate the Overall Response Rate (ORR) per RECIST v1.1 following treatment with Imprime PGG + pembrolizumab in…NCT05159778·Tucson, Arizona and 15 others

RecruitingA Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsThis study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid…NCT07488676·Birmingham, Alabama and 20 others

Not yet recruitingCombination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 TherapyThe objective of this study is to evaluate the safety, feasibility, and preliminary antitumor activity of this multi-component immunotherapy strategy in patients with advanced…NCT07762703·Miami, Florida

CompletedA Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast CancerThe treatment received with sunitinib plus capecitabine could delay tumor growth longer than with treatment with capecitabine alone.NCT00435409·Downey, California and 168 others

TerminatedA Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer PatientsThe purpose of this study is to compare progression-free survival (PFS) in patients with advanced/metastatic breast cancer who have a BRCA mutation when treated with niraparib as…NCT01905592·Tucson, Arizona and 103 others

CompletedEvaluation of the Use of AZD6244 to Induce Increased ER Expression and Anti-Estrogen Response in ER-Negative/Low Breast CancerIf AZD6244 is able to increase ER expression in ER-negative/low cancers then it may be possible to effectively use hormonal therapy in these patients resulting in improved…NCT01313039·Miami, Florida

Active not recruitingDoxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerThis randomized phase III trial studies doxorubicin hydrochloride, cyclophosphamide, and paclitaxel to see how well they work with or without bevacizumab in treating patients with…NCT00433511·Anniston, Alabama and 841 others

CompletedA Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast CancerThis 2 arm study assessed the safety and efficacy of adding intravenous trastuzumab (Herceptin®) to daily oral anastrozole (Arimidex®) tablets as first- and second-line treatment…NCT00022672·Phoenix, Arizona and 131 others

PreviousPage 7 of 20Next

Other Conditions in Miami

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma